We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

RHHBY Roche Holdings Ltd AG (QX)

0.67 (1.99%)
Dec 01 2023 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Roche Holdings Ltd AG (QX) RHHBY OTCMarkets Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.67 1.99% 34.36 16:01:08
Open Price Low Price High Price Close Price Prev Close
34.12 34.12 34.44 34.36 33.69
more quote information »

Recent News

Date Time Source Heading
11/21/202311:06DJNRoche's Genentech, Nvidia Team Up to Accelerate Drug..
11/07/202317:14EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/31/202302:26DJNRoche Says Late-Stage Muscular Dystrophy Trial Didn't Meet..
10/27/202301:40DJNRoche Gets FDA Approval for Vabysmo as Retinal Vein..
10/23/202315:41DJNTrending: Roche to Buy Telavant From Roivant and Pfizer
10/23/202304:16DJNRoche to Buy Telavant From Roivant, Pfizer in Deal Worth Up..
10/23/202301:50DJNRoche to Buy Telavant From Roivant Sciences and Pfizer in..
10/19/202305:55DJNRoche Shares Fall on Lower Sales Due to Currency Hit
10/19/202301:48DJNRoche Backs Guidance After Sales Fall
10/18/202302:14DJNRoche Lung Cancer Drug Reduced Risk of Recurrence, Death in..
10/18/202301:54DJNRoche's Elecsys IL-6 Test Approved for Diagnosis of Neonatal..
9/29/202308:15DJNAbbVie: Phase 3 Venetoclax/Dexamethasone Study Falls Short..
9/27/202307:59DJNIonis, Roche Set New Pact Targeting Alzheimer's,..
9/20/202308:45IHNWPathways to Progress: How Orphan Drug Designation Sparks..
9/06/202301:52DJNRoche's Blood Disorder Drug Crovalimab Takes Step Toward FDA..
9/01/202302:04DJNRoche Lung Cancer Drug Shows Promise in Phase 3 Trial
8/29/202305:51DJNRoche's Tecentriq Intravenous Cancer Therapy Gets UK..
8/29/202301:52DJNRoche Says EU Has Approved Evrysdi for Babies Under Two..
8/23/202305:36DJNRoche Shares Climb After Interim Data Shows Survival Gain in..
8/23/202302:56DJNRoche Says Data From Lung Cancer Trial Was Inadvertently..
7/27/202301:52DJNRoche Backs 2023 Outlook Despite Weaker Covid-19 Demand..
7/21/202310:25DJNRoche Gets EU Recommendation for Evrysdi for Babies Under..
7/14/202307:51IHMARKETNEWSFriday’s Wall Street Highlights: JPMorgan Chase, Coinbase,..
6/16/202301:44DJNRoche Gets FDA Approval for Columvi Lymphoma Treatment
4/26/202301:53DJNRoche 1Q Sales Dragged by Diagnostics Division; Backs 2023..
4/17/202301:44DJNRoche's Tecentriq Shows Further Good Survival Rates as..
3/10/202301:57DJNFDA Committee Backs Roche's Lymphoma Treatment
2/03/202302:24DJNTrending: Roche Guides for 2023 Sales, Earnings Decline on..
2/02/202302:28DJNRoche 2022 Sales Grew, But Expects 2023 Decline on Covid-19..
2/02/202302:02DJNRoche 2022 Sales Grew, But Expects 2023 Decline on Covid-19..
1/09/202313:40DJNSonnet BioTherapeutics Shares Up 8% on Roche Collaboration
12/23/202212:31DJNRoche's Lunsumio Lymphoma Treatment Gets FDA Approval
12/12/202202:26DJNRoche's Phase 3 Data Show Lymphoma Treatment Can Reduce..
12/09/202209:41DJNCorrection to Biogen Actemra Biosimilar Article
12/09/202208:20DJNBiogen: FDA Accepts Application for Actemra Biosimilar
12/07/202207:44DJNReplimune, Roche to Develop RP3 in Colorectal Cancer,..

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |